The Long Window of Preclinical Alzheimer’s Disease: Opportunities for Intervention

Posted June 9, 2017

David Holtzman, M.D., joined us for a WebEx conference on Alzheimer’s and the work he is doing to help us better understand and treat the disease.

Rudy Tanzi, PH.D.: Neuroinflammation and Alzheimer’s Disease

Back to News and Events

Alzstream™ Webinar: Alzheimer’s and the Gut Microbiome

Related Content:

Webinar: Sleep and Circadian Rhythms in Alzheimer’s Disease

Updates and Insights from Our CEO

Webinar: What’s the Role of Inflammation in Alzheimer’s disease?

What’s New In Alzheimer’s Research?

FDA APPROVES KISUNLA™ (DONANEMAB) FOR TREATMENT OF ALZHEIMER’S DISEASE

ADVISORY COMMITTEE (ADCOMM) RESULTS: DONANEMAB